mesowatch
HomeBankruptcy Judge Reverses Split of J&J Tort Committee
divider

Bankruptcy Judge Reverses Split of J&J Tort Committee in Talc Spinoff Case

JNJ talc spinoff ch11 tort case

In a significant turn of events, a New Jersey bankruptcy judge overturned the U.S. Trustee’s decision to divide the tort committee in Johnson & Johnson’s talc spinoff Chapter 11 case. U.S. Bankruptcy Judge Michael Kaplan ruled that the Trustee’s office lacked the authority to override the original court order forming the committee.

The dispute arose when U.S. Trustee Andrew Vara disbanded the original committee, representing all individuals claiming injuries from asbestos-contaminated talc, and appointed two new committees instead: one for ovarian cancer claimants and another for mesothelioma claimants. J&J spinoff LTL Management LLC challenged this decision, arguing that the Trustee’s office overstepped its authority.

During the hearing, Judge Kaplan rejected the Trustee’s arguments, emphasizing that the court has the authority to review such decisions. While the Trustee’s office did not provide reasons for splitting the committee, Michael Klein, counsel for the mesothelioma committee, defended the decision, citing significant differences between the claimant groups.

Although reinstating the original committee may cause disruptions, Judge Kaplan’s ruling underscores the importance of adhering to legal procedures and ensuring proper representation for all parties involved. As the case progresses, creditors affected by the committee split may explore alternative avenues to safeguard their interests within the bankruptcy proceedings.

Johnathan Edwards

Reading Time: 1 mins

Published On: January 19, 2022

Johnathan Edwards - author

Johnathan Edwards Is a husband, father, veteran and medical writer, from the state of California. After serving 9 years in the U.S Army Medical Department, John cultivated his passion for serving his country and helping people. He often volunteers with helping to rehabilitate veterans of all ages. After John’s father was diagnosed with Mesothelioma, he began to research, write and fight for ways to help other victims of asbestos exposure.

More to Read

Section Divider

Amna Anees - November 17, 2024

CHMP Recommends Pembrolizumab and Chemo for Pleural Mesothelioma

Mini Divider
Mesowatch Logo

Mesowatch serves as an industry watchdog and advocates for patients and families affected by asbestos by providing reliable and up-to-date news stories and information on asbestos and mesothelioma.

NAVIGATE

About UsEditorial GuidelinesNewsSupport and ResourcesPrivacy PolicySitemap

CONTACT US

Email: support@mesowatch.com

Phone: (866) 402-1000

Address: 3260 N Hayden Rd, Suite 210, Scottsdale, AZ 85251

Copyright © 2024 by Mesowatch. All Rights Reserved.
At Mesowatch, we strive to provide helpful information for your journey. Please remember that the content on our website is for informational purposes only and is protected by copyright law. It is not a substitute for professional medical or legal advice. We encourage you to consult qualified professionals for any health or legal concerns. Disclaimer